and other specialists who utilize the most advanced technology to diagnose and manage facial nerve disorders. Our model involves a thorough initial assessment of each case, followed by same-day ...

NeuroOne (Nasdaq:NMTC) announced today that it filed an FDA 510(k) submission for its trigeminal nerve ablation technology.

Gangnam Bedro Hospital If your face trembles, such as eyes or lips, it is easy to regard it as a simple symptom due to ...

NeuroOne submits FDA filing early for trigeminal nerve ablation using its OneRF system as the facial pain market sees projected growth to $416 million by 2030.